Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
It is acknowledged that cancer cells are able to undergo senescence in response to clinically used chemotherapeutics. Moreover, recent years have provided evidence that some drugs can selectively remove senescent cells. Therefore, it is essential to properly identify and characterize senescent cells, especially when it comes to cancer. Senescence was induced in various cancer cell lines (A549, SH-SY-5Y, HCT116, MDA-MB-231, and MCF-7) following treatment with doxorubicin, irinotecan, methotrexate, 5-fluorouracil, oxaliplatin, or paclitaxel. Treatment with tested chemotherapeutics resulted in upregulation of p21 and proliferation arrest without cytotoxicity. A comparative analysis with the use of common senescence markers (i.e., morphology, SA-β-galactosidase, granularity, secretory phenotype, and the level of double-stranded DNA damage) revealed a large diversity in response to the chemotherapeutics used. The strongest senescence inducers were doxorubicin, irinotecan, and methotrexate; paclitaxel had an intermediate effect and oxaliplatin and 5-fluorouracil did not induce senescence. In addition, different susceptibility of cancer cells to senescence was observed. A statistical analysis aimed at finding any relationship between the senescence markers applied did not show clear correlations. Moreover, increased SA-β-gal activity coupled with p21 expression proved not to be an unequivocal senescence marker. This points to a need to simultaneously analyze multiple markers, given their individual limitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · cited 1×
“ATM kinase is considered as a pivotal master regulator of cellular senescence, mostly because it phosphorylates the p53 transcriptional factor, which leads to transactivation of the CDKN1A gene and p21 protein production [21].”
BackgroundCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 14×
“SASP production during senescence could be explained by a classic pathway, namely, induction of DNA damage upon drug treatment, followed by upregulation and activation of ATM.”
BackgroundInfluentialBonner, W. M., Redon, C. E., Dickey, J. S., Nakamura, A. J., Sedelnikova, O. A., Solier, S., & Pommier, Y. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2523 · Cited by 1,623
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“A change in the expression level of p53 during the senescence process is likely a critical event, because p53 has antagonistic effects on SASP at least in part by suppressing the activity of p38-MAPK, which is required for NF-κB activation [53].”
BackgroundTelomeric DNA damage is irreparable and causes persistent DNA-damage-response activation
Fumagalli, M., Rossiello, F., Clerici, M., Barozzi, S., Cittaro, D., Kaplunov, J. M., Bucci, G., Dobreva, M., Matti, V., Beausejour, C. M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2466 · Cited by 851
Toussaint, O., Medrano, E. E., & von Zglinicki, T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00180-7 · Cited by 713 · cited 1×
“Normal cells undergo senescence due to telomere erosion, which is known as replicative senescence [7], or due to oncogenes or stress, resulting in oncogene-induced senescence (OIS) [8] or stress-induced premature senescence (SIPS) [9].”
BackgroundThe senescence-associated secretory phenotype and its regulation
Lopes-Paciencia, S., Saint-Germain, E., Rowell, M.-C., Ruiz, A. F., Kalegari, P., & Ferbeyre, G. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.013 · Cited by 601
Pro-senescence therapy for cancer treatment
Nardella, C., Clohessy, J. G., Alimonti, A., & Pandolfi, P. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3057 · Cited by 437
Cellular senescence as a tumor-suppressor mechanism
Campisi, J. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82148-6 · Cited by 390 · cited 1×
“Rb is also activated by another Cdk inhibitor, p16, which acts through the cyclin D/Cdk4,6 complex [31].”
BackgroundIdentification and characterization of Cardiac Glycosides as senolytic compounds
Triana-Martínez, F., Picallos-Rabina, P., Da Silva-Álvarez, S., Pietrocola, F., Llanos, S., Rodilla, V., Soprano, E., Pedrosa, P., Ferreirós, A., Barradas, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12888-x · Cited by 384
Cardiac glycosides are broad-spectrum senolytics
Guerrero, A., Herranz, N., Sun, B., Wagner, V., Gallage, S., Guiho, R., Wolter, K., Pombo, J., Irvine, E. E., Innes, A. J., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0122-z · Cited by 359 · cited 15×
“Human colon HCT116 (CCL-247) cancer cell line was kindly provided by Dr. Bert Vogelstein (Johns Hopkins University, Baltimore, MD, USA).”
BackgroundInfluentialStress, cell senescence and organismal ageing
de Magalhães, J. P., & Passos, J. F. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.07.001 · Cited by 316 · cited 1×
“Many molecular mechanisms and signaling pathways involved in cell senescence induction and acquisition of the senescence phenotype have been recognized [10].”
BackgroundGalanos, P., Vougas, K., Walter, D., Polyzos, A., Maya-Mendoza, A., Haagensen, E. J., Kokkalis, A., Roumelioti, F.-M., Gagos, S., Tzetis, M., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3378 · Cited by 308 · cited 1×
“Furthermore, chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing [40].”
BackgroundYosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V. (2017) · The EMBO Journal · doi:10.15252/embj.201695553 · Cited by 293
Cellular senescence in vivo: a barrier to tumorigenesis
Prieur, A., & Peeper, D. S. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.007 · Cited by 260 · cited 1×
“Indeed, it has been documented that p21 level can be increased, for example, via SK2 [34,35].”
BackgroundRegulation of DNA End Joining, Resection, and Immunoglobulin Class Switch Recombination by 53BP1
Bothmer, A., Robbiani, D. F., Di Virgilio, M., Bunting, S. F., Klein, I. A., Feldhahn, N., Barlow, J., Chen, H.-T., Bosque, D., Callen, E., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.019 · Cited by 244
Quantitative assessment of markers for cell senescence
Lawless, C., Wang, C., Jurk, D., Merz, A., Zglinicki, T. V., & Passos, J. F. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.018 · Cited by 240 · cited 1×
“A negative correlation between SA-β-gal activity and Ki67 expression was clearly shown for replicative senescence of normal human fibroblasts [41].”
BackgroundWang, L., Leite de Oliveira, R., Wang, C., Fernandes Neto, J. M., Mainardi, S., Evers, B., Lieftink, C., Morris, B., Jochems, F., Willemsen, L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.085 · Cited by 224
Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy
Hsu, C.-H., Altschuler, S. J., & Wu, L. F. (2019) · Cell · doi:10.1016/j.cell.2019.05.041 · Cited by 181 · cited 1×
“Moreover, early changes in p21 expression determine whether cells will become senescent or will re-enter the cell cycle after chemotherapy [58].”
Background
Research works printed but not linked: 39
- Chang, 1999, Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs, Oncogene, 18, 4808, 10.1038/sj.onc.1203078 · DOI · Paper page
- Acosta, 2012, Senescence: A new weapon for cancer therapy, Trends Cell Biol., 22, 211, 10.1016/j.tcb.2011.11.006 · DOI · Paper page
- Sikora, 2016, Morphological and Functional Characteristic of Senescent Cancer Cells, Curr. Drug Targets, 17, 377, 10.2174/1389450116666151019094724 · DOI · Paper page
- Schosserer, 2017, The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy, Front. Oncol., 7, 278, 10.3389/fonc.2017.00278 · DOI · Paper page
- Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
- Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. USA, 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
- Mosieniak, 2018, Is DNA damage indispensable for stress-induced senescence?, Mech. Ageing Dev., 170, 13, 10.1016/j.mad.2017.08.004 · DOI
- Strzeszewska, 2018, Insight into the role of PIKK family members and NF-κB in DNAdamage-induced senescence and senescence-associated secretory phenotype of colon cancer cells, Cell Death Dis., 9, 44, 10.1038/s41419-017-0069-5 · DOI
- Scholzen, 2000, The Ki-67 protein: From the known and the unknown, J. Cell Physiol., 182, 311, 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 · DOI · Paper page
- Chapman, 2012, Playing the end game: DNA double-strand break repair pathway choice, Mol. Cell, 47, 497, 10.1016/j.molcel.2012.07.029 · DOI · Paper page
- Chang, 2000, p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells, Oncogene, 19, 2165, 10.1038/sj.onc.1203573 · DOI · Paper page
- Ferrandiz, N., Caraballo, J.M., Garcia-Gutierrez, L., Devgan, V., Rodriguez-Paredes, M., Lafita, M.C., Bretones, G., Quintanilla, A., Muñoz-Alonso, M.J., and Blanco, R. (2012). p21 as a transcriptional co-repressor of S-phase and mitotic control genes. PLoS ONE, 7. · DOI
- Mirzayans, R., Andrais, B., Kumar, P., and Murray, D. (2017). Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome. Int. J. Mol. Sci., 18. · DOI
- Weber, 2015, ATM and ATR as therapeutic targets in cancer, Pharm. Thera., 149, 124, 10.1016/j.pharmthera.2014.12.001 · DOI · Paper page
- Awasthi, 2015, ATM and ATR signaling at a glance, J. Cell Sci., 128, 4255
- Lee, 2019, The dynamic nature of senescence in cancer, Nat. Cell Biol., 21, 94, 10.1038/s41556-018-0249-2 · DOI · Paper page
- Kim, 2019, Cellular senescence in cancer, BMB Rep., 52, 42, 10.5483/BMBRep.2019.52.1.295 · DOI
- Lee, 2019, Cellular senescence: A promising strategy for cancer therapy, BMB Reports, 52, 35, 10.5483/BMBRep.2019.52.1.294 · DOI · Paper page
- Sikora, 2019, Targeting normal and cancer senescent cells as a strategy of senotherapy, Ageing Res. Rev., 55, 100941, 10.1016/j.arr.2019.100941 · DOI · Paper page
- Mosieniak, 2016, Curcumin-treated cancer cells show mitotic disturbances leading to growth arrest and induction of senescence phenotype, Int. J. Biochem. Cell Biol., 74, 33, 10.1016/j.biocel.2016.02.014 · DOI
- Junk, 2008, Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells, Neoplasia, 10, 450, 10.1593/neo.08120 · DOI · Paper page
- Chan, 2011, Novel ARF/p53-independent senescence pathways in cancer repression, J. Mol. Med., 89, 857, 10.1007/s00109-011-0766-y · DOI
- Crescenzi, 2008, Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: Implications for chemotherapy, Clin. Cancer Res., 14, 1877, 10.1158/1078-0432.CCR-07-4298 · DOI
- Korwek, 2012, Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells, DNA Repair (Amst.), 11, 864, 10.1016/j.dnarep.2012.08.006 · DOI
- Liu, 2013, Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer, Future Med. Chem., 5, 991, 10.4155/fmc.13.56 · DOI
- Mosieniak, 2015, Polyploidy Formation in Doxorubicin-Treated Cancer Cells Can Favor Escape from Senescence, Neoplasia, 17, 882, 10.1016/j.neo.2015.11.008 · DOI · Paper page
- Roninson, 2003, Tumor cell senescence in cancer treatment, Cancer Res., 63, 2705
- Yang, 2017, Tumor cell senescence response produces aggressive variants, Cell Death Dis., 3, 17049, 10.1038/cddiscovery.2017.49 · DOI · Paper page
- Xie, 2016, Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells, Onco.Targets Ther., 9, 7115, 10.2147/OTT.S116387 · DOI
- Dabrowska, 2018, Oxidative stress and inhibition of nitric oxide generation underlie methotrexate-induced senescence in human colon cancer cells, Mech. Ageing Dev., 170, 22, 10.1016/j.mad.2017.07.006 · DOI
- Bakkenist, 2018, ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer, Clin Colorectal Cancer, 17, 255, 10.1016/j.clcc.2018.09.001 · DOI
- Manfredi, 1984, Taxol: An antimitotic agent with a new mechanism of action, Pharm. Thera., 25, 83, 10.1016/0163-7258(84)90025-1 · DOI · Paper page
- Jakhar, 2018, Autophagy Governs Protumorigenic Effects of Mitotic Slippage-induced Senescence, Mol. Cancer Res., 16, 1625, 10.1158/1541-7786.MCR-18-0024 · DOI
- Mohammadzadeh, 2019, 53BP1: A key player of DNA damage response with critical functions in cancer, DNA Repair (Amst.), 73, 110, 10.1016/j.dnarep.2018.11.008 · DOI · Paper page
- Johmura, 2016, Multiple facets of p53 in senescence induction and maintenance, Cancer Sci., 107, 1550, 10.1111/cas.13060 · DOI · Paper page
- Piechota, 2016, Is senescence-associated beta-galactosidase a marker of neuronal senescence?, Oncotarget, 7, 81099, 10.18632/oncotarget.12752 · DOI · Paper page
- Sliwinska, 2009, Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells, Mech. Ageing Dev., 130, 24, 10.1016/j.mad.2008.04.011 · DOI · Paper page
- Was, 2018, Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features, Cancer Biol. Ther., 19, 63, 10.1080/15384047.2017.1385675 · DOI · Paper page
- Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J. Clin., 68, 394, 10.3322/caac.21492 · DOI · Paper page
Cited by
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska-Kołat, Ż., Celik, I., & Kontek, R. (2023) · Cells · doi:10.3390/cells12040659 · Cited by 810
A guide to assessing cellular senescence in vitro and in vivo
González‐Gualda, E., Baker, A. G., Fruk, L., & Muñoz‐Espín, D. (2021) · The FEBS Journal · doi:10.1111/febs.15570 · Cited by 645
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Saleh, T., Bloukh, S., Carpenter, V. J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., & Gewirtz, D. A. (2020) · Cancers · doi:10.3390/cancers12040822 · Cited by 290
Saleh, T., Carpenter, V. J., Tyutyunyk‐Massey, L., Murray, G., Leverson, J. D., Souers, A. J., Alotaibi, M. R., Faber, A. C., Reed, J., Harada, H., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12761 · Cited by 190
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
Carpenter, V. J., Saleh, T., & Gewirtz, D. A. (2021) · Cancers · doi:10.3390/cancers13040723 · Cited by 124
Metadata
- Authors
- Bojko, A., Czarnecka-Herok, J., Charzynska, A., Dabrowski, M., & Sikora, E.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-11-23
- Volume
- 8
- Issue
- 12
- Pages
- 1501
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2991467764
- Cited by
- 108
- References
- 22
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.